FDA approves first test to help screen for risk of opioid use disorder

The US Food and Drug Administration approved a novel tool Tuesday that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder.

Related Keywords

United States ,Andrew Saxon ,Jeff Shuren ,Autogenomics Avert ,Katherine Keyes ,Us Centers For Disease ,Us Department Of Health ,Columbia University Mailman School Of Public Health ,University Of Washington School Medicine ,Radiological Health ,Human Services ,Drug Administration ,Autogenomics Avertd ,Washington School ,Columbia University Mailman School ,Public Health ,Disease Control , ,